COPD Maintenance Drug Approved by FDA | ThirdAge
Links shared publicly online about this topic.
- 470total visits
COPD Maintenance Drug Approved by FDA | ThirdAge
View full resource at thirdage.com
Tags: Lung, COPD, Disease and Condition, Drug, FDA, Pulmonology, disease
Most Recently Shared on March 1, 2011 at 9:00 pm By:
FDA Approves Arcapta Neohaler To Treat Chronic Obstructive Pulmonary Disease - QualityPoint Technologies
qualitypointtech.net — “The U.S. Food and Drug Administration approved Arcapta Neohaler (indacaterol inhalation powder) for the long term, once-daily maintenance bronchodilator treatment of airflow obstruction in people with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and/or emphysema. COPD is a serious lung disease that makes breathing difficult. Symptoms can include breathlessness, chronic cough and excessive phlegm...” View full resource at qualitypointtech.net
Most Recently Shared on July 3, 2011 at 8:45 am By:
FDA Approves Arcapta Neohaler To Treat Chronic Obstructive Pulmonary Disease: The U.S. Food and Drug Administratio... http://bit.ly/iCpKuD
Novartis Announces FDA Approval For Arcapta To Treat COPD Symptoms
rttnews.com — “Novartis AG (NVS), Friday announced that the US Food and Drug Administration has approved once-daily Arcapta Neohaler (indacaterol inhalation powder) 75 mcg for the long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease.” View full resource at rttnews.com
Most Recently Shared on July 2, 2011 at 2:30 am By:
Novartis Announces FDA Approval For Arcapta To Treat COPD Symptoms, once a day bronchodilator - http://goo.gl/cd9hS
New Inhaler Drug for COPD Approved - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease, the agency announced.” View full resource at qualitypointtech.net
Most Recently Shared on July 1, 2011 at 11:00 pm By:
New Inhaler Drug for COPD Approved: WASHINGTON (MedPage Today) -- A new beta2-adrenergic agonist drug, indacaterol... http://bit.ly/iGWeAq
Medical News: New Inhaler Drug for COPD Approved - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “WASHINGTON -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease, th” View full resource at medpagetoday.com
Most Recently Shared on July 1, 2011 at 10:13 pm By:
Medpage Today: New Inhaler Drug for COPD Approved http://bit.ly/kTxsDs Full http://bit.ly/iZucPv
Medical News: New Inhaler Drug for COPD Approved - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “WASHINGTON -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease, th” View full resource at medpagetoday.com
Most Recently Shared on July 1, 2011 at 10:11 pm By:
Medical News: FDA Okays COPD Maintenance Drug - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved the phosphodiesterase-4 inhibitor roflumilast (Daliresp) to prevent COPD exacerbations, despite a negative advisory panel vote last year.” View full resource at medpagetoday.com
Most Recently Shared on March 1, 2011 at 5:28 pm By:
Medical News: FDA Okays COPD Maintenance Drug - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved the phosphodiesterase-4 inhibitor roflumilast (Daliresp) to prevent COPD exacerbations, despite a negative advisory panel vote last year.” View full resource at medpagetoday.com
Most Recently Shared on March 1, 2011 at 4:50 pm By:
Medpage Today: FDA Okays COPD Maintenance Drug http://bit.ly/hbVv4V Full http://bit.ly/emdYZW
Advertisement

